Calatroni, Marta
 Distribuzione geografica
Continente #
NA - Nord America 1.935
AS - Asia 1.406
EU - Europa 486
SA - Sud America 173
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 29
OC - Oceania 3
Totale 4.138
Nazione #
US - Stati Uniti d'America 1.872
SG - Singapore 758
CN - Cina 354
IT - Italia 246
BR - Brasile 138
VN - Vietnam 126
HK - Hong Kong 54
DE - Germania 32
GB - Regno Unito 32
FI - Finlandia 31
IE - Irlanda 29
CA - Canada 26
IN - India 25
MK - Macedonia 20
MX - Messico 19
BD - Bangladesh 15
FR - Francia 15
PL - Polonia 14
AR - Argentina 13
NL - Olanda 13
PH - Filippine 11
TR - Turchia 9
UA - Ucraina 9
ES - Italia 8
RU - Federazione Russa 8
IQ - Iraq 7
PK - Pakistan 7
CO - Colombia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
JP - Giappone 5
SE - Svezia 5
TN - Tunisia 5
VE - Venezuela 5
AT - Austria 4
CL - Cile 4
EG - Egitto 4
LV - Lettonia 4
MA - Marocco 4
NG - Nigeria 4
TW - Taiwan 4
AU - Australia 3
AZ - Azerbaigian 3
DZ - Algeria 3
EE - Estonia 3
NI - Nicaragua 3
PA - Panama 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
ET - Etiopia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BS - Bahamas 1
CR - Costa Rica 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
MT - Malta 1
MZ - Mozambico 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UG - Uganda 1
Totale 4.032
Città #
Singapore 371
San Jose 250
Ashburn 229
Shanghai 112
Beijing 109
The Dalles 98
Milan 93
Council Bluffs 88
Dallas 86
New York 75
Boardman 65
Santa Clara 60
Hong Kong 53
Los Angeles 45
Ho Chi Minh City 38
Hanoi 35
Rome 32
Helsinki 31
Phoenix 30
Dublin 29
Naples 26
Brooklyn 19
Chandler 19
Seattle 14
Princeton 11
Washington 11
Wilmington 11
Buffalo 10
Haiphong 10
Houston 10
Mexico City 10
Warsaw 10
Orem 9
Skopje 9
Assago 8
Atlanta 8
London 8
Orlando 8
São Paulo 8
Chicago 7
Frankfurt am Main 7
Montreal 7
Paris 7
Charlotte 6
Chennai 6
Figino 6
Fort Worth 6
Las Vegas 6
Rio de Janeiro 6
San Francisco 6
Amsterdam 5
Bitola 5
Boston 5
Detroit 5
Istanbul 5
Jacksonville 5
Katy 5
Philadelphia 5
Richmond 5
Tampa 5
The Bronx 5
Baltimore 4
Benin City 4
Buenos Aires 4
Da Nang 4
Denver 4
Neipu 4
Riga 4
Santiago 4
Springfield 4
Stockholm 4
Tokyo 4
Toronto 4
Worcester 4
Abbeville 3
Baku 3
Baton Rouge 3
Belo Horizonte 3
Bowling Green 3
Colorado Springs 3
Columbus 3
Converse 3
Dubai 3
Greenville 3
Hillsboro 3
Karachi 3
Kyiv 3
Lafayette 3
Lancaster 3
Managua 3
McDonough 3
Miami 3
Minneapolis 3
Mumbai 3
Munich 3
Nashville 3
Olongapo City 3
Panama City 3
Pasadena 3
Poplar 3
Totale 2.403
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 230
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 149
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohort 139
Herpes zoster in lupus nephritis: experience on 292 patients followed up for 15 years 98
Kidney Biopsy in Pregnant Women with Glomerular Diseases: Focus on Lupus Nephritis 84
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 84
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 84
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 81
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration 81
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 79
Goodpasture syndrome and anti-glomerular basement membrane disease 78
Renal sarcoidosis 78
[Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis] 77
Is per-protocol kidney biopsy required in lupus nephritis? 75
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children 74
ANCA-associated vasculitis in childhood: Recent advances 73
Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review 72
{"}Deep{"} purple urine bag syndrome: physiopathology and clinical implications,La Sindrome delle urine viola: patogenesi e significato clinico 71
Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients 71
Understanding fluid dynamics and renal perfusion in acute kidney injury management 69
Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis 68
Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review 68
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 67
Global Performance Status Score: A New Tool to Assess Physical Performance in Kidney Transplant Patients 64
Blood Thiol Redox State in Chronic Kidney Disease 64
Anti-neutrophil cytoplasmic antibody-associated vasculitis in kidney transplantation 62
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 62
Monoclonal gammopathy in lupus nephritis 61
Renal replacement therapy in sarcoidosis 61
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 61
Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients 60
Anti-glomerular basement membrane vasculitis 59
Microplastics and Kidneys: An Update on the Evidence for Deposition of Plastic Microparticles in Human Organs, Tissues and Fluids and Renal Toxicity Concern 58
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome 58
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 58
Immunohistochemical Evaluation of Renal Biopsy with Anti-PD1 and p53 to Solve the Dilemma between Platinum- and Pembrolizumab-Induced AKI: Case Report and Review 58
Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis 57
Anti-C1Q monitoring predicts relapses of lupus nephritis 57
C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis 57
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: Clinico-pathological characterization and outcome 56
Spontaneous rupture of a simple renal cyst: clinical management [Rottura spontanea di cisti renale semplice: gestione clinica] 54
Renal involvement in eosinophilic granulomatosis with polyangiitis 54
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 54
Integrated protocol for the prevention and treatment of skin ulcers in patients with end-stage renal disease 54
Hospital Malnutrition in the Medicine and Neurology Departments: A Complex Challenge 52
Renal involvement in mushroom poisoning: The case of Orellanus syndrome 51
Enhancing clinical nutrition education for healthcare professionals: Engagement through active learning methodologies 51
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 51
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 50
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons 48
The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis 47
The Impact of Preeclampsia in Lupus Nephritis 43
Volume balance in chronic kidney disease: Evaluation methodologies and innovation opportunities 42
Severe lupus nephritis in the present days 36
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 33
Not So Benign: Revisiting Pure Membranous Lupus Nephritis 31
CRITICAL ROLE OF DYSREGULATED AUTOPHAGY IN PATHOPHYSIOLOGY OF PODOCYTOPATHY 28
Chronic kidney disease trajectories in lupus nephritis: Is progression unavoidable? 28
Predictors of Long-term Response in Patients With Lupus Nephritis 26
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritis 25
Pain, quality of life, work ability and psychosocial well-being in living kidney donors: A scoping review 24
Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis 21
The Recurrence of Systemic Diseases in Kidney Transplantation 21
Diagnostic challenge of high vitamin B12 levels: a case report and review of the literature 19
Malignancies in lupus nephritis: a retrospective cohort study on epidemiology and risk factors 18
Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset 16
Editorial: Exploring the impact of biologics in nephrology: clinical advances and future perspectives 16
Editorial: Kidney and heart cross-talk 15
Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 15
Three years is the minimal effective duration of sustained clinical remission which prevents impaired kidney function and damage accrual in lupus nephritis 15
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 14
Evaluation of renal functional reserve with oral protein load or new ultrasound test 12
Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis 11
Totale 4.138
Categoria #
all - tutte 22.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 2 0 0 1 2 0 2 9 1
2022/2023104 5 2 4 3 7 7 4 6 20 5 7 34
2023/2024496 58 22 76 46 18 63 57 35 17 6 42 56
2024/2025738 10 41 14 20 20 59 29 88 106 154 101 96
2025/20261.895 253 112 67 124 108 117 481 114 91 148 130 150
2026/2027853 219 202 427 5 0 0 0 0 0 0 0 0
Totale 4.138